At BioXera, we believe that maintaining the highest quality benchmarks goes beyond regulatory obligation; it is a fundamental responsibility to our customers and, ultimately, to the patients who depend on the integrity of the medicines they receive.
Robust quality standards are upheld across the entire API lifecycle — from R&D to raw material evaluation to final product release — ensuring consistency, safety, and compliance at every stage.
Our manufacturing operations are conducted in accordance with cGMP guidelines and meet the stringent requirements of leading global regulatory bodies like EU GMP, Korean MFDS, WHO GMP. The robustness of our quality systems is further validated through regular customer audits, reflecting the confidence our partners place in our processes and standards.
Copyright 2014 Bioxera Pharma Private Limited | Legal Disclaimer